CELEX: 62019TA0261
Language: en
Date: 2021-01-20 00:00:00
Title: Case T-261/19: Judgment of the General Court of 20 January 2021 — Stada Arzneimittel v EUIPO — Optima Naturals (OptiMar) (EU trade mark — Opposition proceedings — Application for the EU figurative mark OptiMar — Earlier national word mark Mar — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

1.3.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 72/21
            
         
      Judgment of the General Court of 20 January 2021 — Stada Arzneimittel v EUIPO — Optima Naturals (OptiMar)
      (Case T-261/19) (1)
      
      (EU trade mark - Opposition proceedings - Application for the EU figurative mark OptiMar - Earlier national word mark Mar - Relative ground for refusal - No likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))
      (2021/C 72/30)
      Language of the case: English
      
         Parties
      
      
         Applicant: Stada Arzneimittel AG (Bad Vilbel, Germany) (represented by: J.-C. Plate and R. Kaase, lawyers)
      
         Defendant: European Union Intellectual Property Office (represented by: A. Folliard-Monguiral and V. Ruzek, acting as Agents)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Optima Naturals Srl (Gallarate, Italy) (represented by: S. Brustia and E. Montelione, lawyers)
      
         Re:
      
      Action brought against the decision of the First Board of Appeal of EUIPO of 31 January 2019 (Case R 1348/2018-1), relating to opposition proceedings between Stada Arzneimittel and Optima Naturals.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Stada Arzneimittel AG to pay the costs.
               
            
         (1)  OJ C 206, 17.6.2019.